JUAN G CAMAYD

Allopathic & Osteopathic Physicians|General Practice MIAMI, FL NPI 1124004577

General Payments — all program years on this page

$8,470.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 418
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $404.31 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $404.3121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,824.1677
2019 $1,760.0069
2020 $1,415.1476
2021 $1,458.5688
2022 $946.6754
2023 $661.5433
2024 $404.3121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086776621 Novartis Pharmaceuticals Corporation $17.58 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103407299 ABBVIE INC. $24.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104337064 AstraZeneca Pharmaceuticals LP $18.59 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104682175 AstraZeneca Pharmaceuticals LP $18.46 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114457315 Exact Sciences Corporation $22.26 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114457318 Exact Sciences Corporation $21.50 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114457322 Exact Sciences Corporation $21.25 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114457326 Exact Sciences Corporation $25.64 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114457330 Exact Sciences Corporation $23.14 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216240 Amgen Inc. $15.84 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216242 Amgen Inc. $20.17 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216244 Amgen Inc. $19.38 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117880215 Boehringer Ingelheim Pharmaceuticals, Inc. $24.57 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131466398 PFIZER INC. $19.46 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131570096 PFIZER INC. $19.22 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131574827 PFIZER INC. $15.00 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135075089 Lilly USA, LLC $14.30 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135089641 Lilly USA, LLC $13.33 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135110276 Lilly USA, LLC $18.91 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135111172 Lilly USA, LLC $14.06 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139265042 Astellas Pharma US Inc $17.65 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.